Goleta-based breast implant manufacturer Sientra announced an increase in net losses for the third quarter of 2017 to $14.4 million after operating expenses increased nearly 40 percent. Net sales reached $9.8 million, up 50 percent from the same period in 2016, but general and administrative costs rose more than 60 percent, driving total operating costs…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
